Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionProfund Advisors Llc
Latest Disclosed Ownership17,687 shares
Latest Disclosed Value $ 2,330,085
Profund Advisors Llc reports 12.66% increase in ownership of NBIX / Neurocrine Biosciences, Inc.

On April 24, 2026 - Profund Advisors Llc filed a 13F-HR form disclosing ownership of 17,687 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $2,330,085 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 15,700 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 12.66% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,687 1,987 12.66 2,330 4.67 0.0855
2026-02-06 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,700 1,631 11.59 2,227 12.71 0.0677
2025-11-06 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 14,069 -3,657 -20.63 1,975 -11.32 0.0642
2025-08-07 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,726 -4,327 -19.62 2,228 -8.69 0.0802
2025-05-08 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 22,053 330 1.52 2,439 -17.74 0.1060
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 21,723 -7,385 -25.37 2,965 -11.57 0.1083
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 29,108 4,791 19.70 3,354 0.18 0.1269
2024-08-13 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 24,317 10,405 74.79 3,348 74.50 0.1241
2024-05-08 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,912 -1,359 -8.90 1,919 -4.67 0.0747
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,271 -736 -4.60 2,012 11.78 0.0864
2023-11-13 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,007 -2,847 -15.10 1,801 1.29 0.0996
2023-08-10 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,854 2,636 16.25 1,778 8.29 0.0954
2023-05-12 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,218 2,330 16.78 1,642 -1.03 0.1014
2023-02-02 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,888 305 2.25 1,659 14.90 0.1076
2022-11-07 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,583 -512 -3.63 1,443 5.02 0.1038
2022-08-01 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 14,095 -1,483 -9.52 1,374 -5.89 0.0873
2022-05-10 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,578 -1,696 -9.82 1,460 -0.75 0.0613
2022-02-08 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,274 -2,636 -13.24 1,471 -22.98 0.0481
2021-11-12 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,910 -1,233 -5.83 1,910 -7.19 0.0644
2021-08-12 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 21,143 -437 -2.03 2,058 -1.95 0.0691
2021-05-14 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 21,580 2,540 13.34 2,099 15.01 0.0807
2021-02-09 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,040 1,708 9.85 1,825 9.48 0.0797
2020-11-13 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,332 -3,247 -15.78 1,667 -33.61 0.0858
2020-08-03 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 20,579 3,274 18.92 2,511 67.62 0.1397
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,305 -6,312 -26.73 1,498 -41.00 0.1125
2020-02-18 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 23,617 2,541 12.06 2,539 33.70 0.1106
2019-11-12 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 21,076 -1,413 -6.28 1,899 0.00 0.0960
2019-08-13 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 22,489 -2,816 -11.13 1,899 -14.80 0.0900
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 25,305 387 1.55 2,229 25.30 0.1072
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 24,918 -6,011 -19.43 1,779 -53.22 0.1100
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 30,929 3,018 10.81 3,803 38.69 0.1443
2018-08-13 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 27,911 -1,399 -4.77 2,742 12.79 0.1095
2018-05-14 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 29,310 -3,104 -9.58 2,431 -3.34 0.0968
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 32,414 -4,077 -11.17 2,515 12.48 0.0970
2017-11-13 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 36,491 2,889 8.60 2,236 44.63 0.0931
2017-08-11 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 33,602 -1,919 -5.40 1,546 0.52 0.0700
2017-04-25 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 35,521 -2,832 -7.38 1,538 3.64 0.0687
2017-02-13 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 38,353 -6,069 -13.66 1,484 -34.04 0.0683
2016-11-10 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 44,422 1,377 3.20 2,250 15.03 0.1070
2016-08-12 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 43,045 -3,972 -8.45 1,956 5.16 0.0952
2016-05-06 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 47,017 -10,859 -18.76 1,860 -43.19 0.0964
2016-02-05 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 57,876 -225 -0.39 3,274 41.61 0.1554
2015-11-06 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 58,101 58,101 2,312 0.1317
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.